IRIS
BACCARANI, Umberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.584
EU - Europa 4.817
AS - Asia 1.166
Continente sconosciuto - Info sul continente non disponibili 20
AF - Africa 19
SA - Sud America 3
OC - Oceania 1
Totale 23.610
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.490
UA - Ucraina 1.651
DE - Germania 1.190
CN - Cina 793
IT - Italia 737
FI - Finlandia 526
IE - Irlanda 314
TR - Turchia 175
SE - Svezia 167
CA - Canada 91
GB - Regno Unito 75
VN - Vietnam 69
IN - India 51
IR - Iran 49
FR - Francia 47
RU - Federazione Russa 43
BE - Belgio 30
EU - Europa 20
TG - Togo 11
KR - Corea 9
NL - Olanda 9
TW - Taiwan 8
EG - Egitto 7
PL - Polonia 6
HK - Hong Kong 4
RO - Romania 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
BR - Brasile 2
CH - Svizzera 2
EE - Estonia 2
ES - Italia 2
HR - Croazia 2
LI - Liechtenstein 2
MD - Moldavia 2
PA - Panama 2
AL - Albania 1
AT - Austria 1
AU - Australia 1
CL - Cile 1
DK - Danimarca 1
IL - Israele 1
IQ - Iraq 1
JP - Giappone 1
MA - Marocco 1
MX - Messico 1
NO - Norvegia 1
PH - Filippine 1
RS - Serbia 1
SG - Singapore 1
TH - Thailandia 1
Totale 23.610
Salva come PNG Salva come JPEG
Città #
Fairfield 2.735
Woodbridge 1.814
Ashburn 1.304
Houston 1.291
Jacksonville 1.164
Chandler 1.145
Wilmington 1.075
Seattle 1.043
Cambridge 977
Ann Arbor 924
Dearborn 760
Udine 474
Beijing 383
Princeton 329
Dublin 314
Izmir 171
San Diego 151
Hefei 76
Ogden 76
Dong Ket 69
Ottawa 68
Norwalk 56
Des Moines 53
Nanjing 49
Kunming 46
Boardman 37
New York 31
Brussels 30
Washington 27
Redmond 25
Helsinki 24
Jinan 23
Guangzhou 22
Leawood 22
Nanchang 21
Augusta 20
Grafing 19
Ardabil 18
Monmouth Junction 17
Toronto 17
Milan 16
Pune 16
San Mateo 16
Chengdu 15
Trieste 15
Fuzhou 14
Zanjan 13
Simi Valley 12
Lomé 11
Phoenix 11
Rome 11
Ningbo 8
Redwood City 8
Shenyang 8
Zhengzhou 8
Hebei 7
Taipei 7
Xian 7
Auburn Hills 6
London 6
Saint Petersburg 6
Shaoxing 6
Andover 5
Changsha 5
Latisana 5
Murano 5
Sacramento 5
Shanghai 5
Wuhan 5
Baotou 4
Chongqing 4
Dallas 4
Hong Kong 4
Indiana 4
Taizhou 4
Venezia 4
Xiamen 4
Bologna 3
Cairo 3
Charlotte 3
Frankfurt am Main 3
Hangzhou 3
Henderson 3
Kraków 3
Mumbai 3
Shenzhen 3
Torino 3
Warsaw 3
Agugliano 2
Amsterdam 2
Bengaluru 2
Chaoyang 2
Chisinau 2
Colle Umberto 2
Cormeilles-en-Parisis 2
Edinburgh 2
Falls Church 2
Fremont 2
Gangnam-gu 2
Huzhou 2
Totale 17.251
Salva come PNG Salva come JPEG
Nome #
Extended Ureteral Stricture Corrected with Appendiceal Replacement in a Kidney Transplant Recipient 225
In vitro functional assessment of a porcine hepatocytes based bioartificial liver 183
LONG-TERM OUTCOMES OF ORTHOTOPIC LIVER TRANSPLANTATION IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS AND COMPARISON WITH HUMAN IMMUNODEFICIENCY VIRUS-NEGATIVE CASES 162
Steatosis of the graft is a risk factor for posttransplantation biliary complications. 155
Hepatitis B-core antibody positive donors in liver transplantation and their impact on graft survival: Evidence from the Liver Match cohort study 151
Improved survival in liver transplant recipients receiving prolonged-release tacrolimus in the European liver transplant registry 149
Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV recipients. 147
A comparative prospective study of two available solutions for kidney and liver preservation 141
A single-center experience of late retransplantation of the liver. 141
Laparoscopic sleeve gastrectomy as a weight reduction strategy in obese patients after kidney transplantation 140
La splenectomia laparotomica e laparoscopica 135
Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching 133
A Matched Pair Analysis of Multicenter Long-term Follow-up after Split Liver Transplantation with Extended Right Grafts 130
Splenic Artery Syndrome as a Possible Cause of Late Onset Refractory Ascites after Liver Transplantation: Management with Proximal Splenic Artery Embolization 129
Impact of surgical complications on the risk of hepatocellular carcinoma recurrence after hepatic resection 129
Fifteen years and 382 extended right grafts from in situ split livers in a multicenter study: Are these still extended criteria liver grafts? 128
Differential proteomic analysis of hepatocellular carcinoma 127
Impact of new treatment options for hepatitis c virus infection in liver transplantation 126
Diaphragm rupture in a liver transplant patient under chronic immunosuppressive therapy with sirolimus: rare complication after liver transplantation 124
Postsplenectomy recurrence of idiopathic thrombocitopenic purpura: role of laparoscopic splenectomy in the treatment of accessory spleen 124
Antiretroviral blood levels in HIV/HCV-coinfected patients with cirrhosis after liver transplant: A report of three cases 122
Donor safety in living donor liver donation: An Italian multicenter survey 122
Laparoscopic treatment of symptomatic lymphoceles after kidney transplantation 121
Development of Small Bowel Volvulus on Barbed V-Loc™ Suture: A Rare Complication after Laparoscopic Ventral Rectopexy 120
Liver transplantation from old donors into HCV and non-HCV recipients 119
BENEFIT OF LAPAROSCOPY FOR RECTAL RESECTION IN PATIENTS OPERATED SIMULTANEOUSLY FOR SYNCHRONOUS LIVER METASTASES: PRELIMINARY EXPERIENCE. 119
Ileocecal Fistula Caused by Multiple Foreign Magnetic Bodies Ingestion 118
Transarterial chemoembolization does not harm the hepatic artery at transplantation 118
Transesophageal echocardiography in orthotopic liver transplantation: a comprehensive intraoperative monitoring tool 116
Liver Retransplantation in Patients with HIV-1 Infection: An International Multicenter Cohort Study 116
Future of minimally invasive surgery 115
Isolation of Human Hepatocytes from Livers Rejected for Liver Transplantation on a National Basis: Results of a 2 Year-Experience 114
Safety of conversion from twice-daily tacrolimus (Prograf) to once-daily prolonged-release tacrolimus (Advagraf) in stable liver transplant recipients 113
De Novo Solid Tumors after Kidney Transplantation: Is It Time for a Patient-Tailored Risk Assessment? Experience from a Single Center 112
Detection of transplant renal artery stenosis with contrast-enhanced ultrasound 112
Biliary pharmacodynamic exposure to linezolid in two liver transplant patients. 111
DE NOVO TUMORS ARE A MAJOR CAUSE OF LATE MORTALITY AFTER ORTHOTOPIC LIVER TRANSPLANTATION 111
Predictors of endoscopic treatment outcome in the management of biliary complications after orthotopic liver transplantation 111
Quality-of-life assessment before and after liver transplantation. 110
Pharmacokinetic Profile of Prolonged-Release Tacrolimus When Administered via Nasogastric Tube in De Novo Liver Transplantation: A Sub-Study of the DIAMOND Trial 110
Safety and efficacy of splenic artery embolization for portal hyperperfusion in liver transplant recipients: A 5-year experience 110
Biliary penetration and pharmacodynamic exposure of linezolid in liver transplant patients 109
Sequential versus contemporaneous portal and arterial reperfusion during liver transplantation. 109
Complete Remission of Unresectable Hepatocellular Carcinoma after Combined Sorafenib and Adjuvant Yttrium-90 Radioembolization 108
Treatment of Candida Infections with Fluconazole in Adult Liver Transplant Recipients: Is TDM-guided Dosing Adaptation Helpful? 108
Steatotic versus cirrhotic livers as a source for human hepatocyte isolation 107
null 107
RENAL ALLOGRAFT PROTECTION WITH EARLY ANGIOTENSIN-CONVERTING ENZYME INHIBITORS ADMINISTRATION 107
Intra-abdominal penetration and pharmacodynamic exposure to fluconazole in three liver transplant patients with deep-seated candidiasis 107
HIV-INFECTED PATIENTS AND LIVER TRANSPLANTATION: WHO, WHEN AND WHY 106
Portal vein thrombosis after intraportal hepatocytes transplantation in a liver transplant recipient 106
TREATMENT OF RECURRENT SYMPTOMATIC LYMPHOCELE AFTER KIDNEY TRANSPLANTATION WITH INTRAPERITONEAL TENCKHOFF CATHETER 106
De novo malignancies after liver and kidney transplantations: A single center experience on 582 consecutive cases. 105
Hyperlactacidemia Potentially Due to Linezolid Overexposure in a Liver Transplant Recipient 105
Single-time kidney transplantation and monolateral nephrectomy for hypertension and antihypertensive therapy in renal transplant recipients 105
Cryopreserved human hepatocytes from cell bank: In vitro function and clinical application 104
Acute pancreatitis after kidney transplantation. 103
Technical solutions for venous outflow reconstruction in damaged liver grafts during procurement: Case reports 103
Arterial rupture as the result of fungal arteritis after renal transplantation 102
Transient ischemic attack after rizatriptan administration in a liver transplant recipient: A case report 101
DE NOVO GASTROINTESTINAL TUMOURS AFTER RENAL TRANSPLANTATION: ROLE OF CMV AND EBV VIRUSES 101
MeltDose Technology vs Once-Daily Prolonged Release Tacrolimus in De Novo Liver Transplant Recipients 101
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. 100
De novo malignancies after kidney and liver transplantations: experience on 582 consecutive cases. 100
STEATOSIS OF THE HEPATIC GRAFT AS A RISK FACTOR FOR POST-TRANSPLANT BILIARY COMPLICATIONS 99
COMBINED APPROACH FOR SPONTANEOUS RUPTURE OF HEPATOCELLULAR CARCINOMA 99
A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list. 99
Head and neck and esophageal cancers after liver transplant: Results from a multicenter cohort study. Italy, 1997-2010 99
Hepatocyte isolation using human livers discarded from transplantation: Analysis of cell yield and function 98
Long-term placement of subcutaneous Rusch-type stents for double biliary stenosis in a living-donor liver transplant recipient 98
Split and whole liver transplantation outcomes: A comparative cohort study 98
APURINIC APYRIMIDINIC ENDONUCLEASE/REDOX EFFECTOR FACTOR 1 IMMUNOREACTIVITY AND GRADING IN HEPATOCELLULAR CARCINOMA RISK OF RELAPSE AFTER LIVER TRANSPLANTATION 98
Overoxidation of peroxiredoxins as an immediate and sensitive marker of oxidative stress in HepG2 cells and its application to the redox effects induced by ischemia/reperfusion in human liver 98
Liver Transplant in Patients with HIV: Infection Risk Associated with HIV and Post-transplant Immunosuppression 98
Comparison of clinical and pathological staging and long-term results of liver transplantation for hepatocellular carcinoma in a single transplant center 97
Steatosis of the hepatic graft as a risk factor for post-transplant biliary complications 97
Surgical staging in Hodgkin's disease: the role of laparoscopic splenectomy 97
IMMUNESUPPRESSION AND CANCER: A COMPARISON OF RISKS IN RECIPIENTS OF ORGAN TRANSPLANTS AND HIV-POSITIVE INDIVIDUALS 97
Current preventive strategies and management of Epstein-Barr virus-related post-transplant lymphoproliferative disease in solid organ transplantation in Europe. Results of the ESGICH Questionnaire-based Cross-sectional Survey 97
Early post-liver transplant surgical morbidity in HIV infected recipients: risk factor for overall survival? A nationwide retrospective study 97
Laparoscopic versus open splenectomy in the management of splenomegaly: our preliminary experience 96
Angiotensin-converting enzyme inhibitors reduce hemoglobin concentrations, hematocrit, and serum erythropoietin levels in renal transplant recipients without posttransplant erythrocytosis 96
Multipotent cells can be generated in vitro from several adult human organs (heart, liver and bone marrow) 96
Liver resection for hepatocellular carcinoma: A multivariate analysis of factors associated with improved prognosis. The role of clinical, pathological and surgical related factors 96
Perioperative intra- and extravascular volume in liver transplant recipients. 96
Risk of virus and non-virus related malignancies following immunosuppression in a cohort of liver transplant recipients. Italy, 1985–2014 96
Selective bilirubin Removal by Plasma Treatment With Plasorba BR-350 for Early Cholestatic Graft Dysfunction 95
OCCULT HEPATITIS B VIRUS INFECTION IN LIVER TRANSPLANT RECIPIENTS WITH RECURRENT HEPATITIS C: RELATIONSHIP WITH DONOR AGE AND FIBROSIS PROGRESSION 95
Non-erosive and uncomplicated erosive reflux diseases: Difference in physiopathological and symptom pattern. 95
. Quantification of human livers as an effective source of hepatocytes for clinical application 94
A Simple Trick for Optimizing the Three-Vein Technique Outflow Anastomosis in Piggyback Liver Transplantation 94
CARDIOVASCULAR RISK FACTORS AND IMMUNOSUPPRESSIVE REGIMEN AFTER LIVER TRANSPLANTATION 94
Appendicectomy and Crohn's disease: clinical and genetic associations 94
Liberase HI enzyme versus collagenase type P for porcine hepatocyte isolation 93
Role of tumor associated fibroblasts in human liver regeneration, cirrhosis, and cancer. 93
Pros and cons of liver transplantation in human immunodeficiency virus infected recipients 93
Tacrolimus Therapeutic Drug Monitoring in Stable Kidney Transplantation and Individuation of CYP3A5 Genotype 93
Role of cytomegalovirus and Epstein-Barr virus in patients with de novo colon cancer after renal transplantation. 92
Successful minimally invasive management of late portal vein thrombosis after splenectomy due to splenic artery steal syndrome following liver transplantation: a case report 92
Effects of mycophenolate mofetil and azathioprine on the erythropoietin production in renal transplant recipients 91
Totale 11.159
Salva come PNG Salva come JPEG
Categoria #
all - tutte 71.341
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.341
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192.197 0 0 0 0 0 0 0 0 0 422 1.063 712
2019/20207.693 406 401 284 1.082 629 1.208 925 864 592 623 237 442
2020/20214.354 117 473 138 472 284 505 315 534 593 170 515 238
2021/20222.537 109 280 73 128 36 97 168 139 34 472 604 397
2022/20232.599 358 214 41 335 237 704 6 170 338 31 70 95
2023/2024842 115 89 43 26 162 152 12 81 138 24 0 0
Totale 24.084